Meiji Holdings agrees to drug venture. Meiji Holdings stock sits 7.38 percent below its high

Published on 10/13/2026 at 07:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Meiji Holdings stock saw JPY 22.673 billion profit in fiscal 2027's first quarter. Market value was JPY 1.2 trillion on October 13, 2026.

Key points in brief

Meiji Holdings agreed to a generic-drug venture disclosed on September 30, 2026.
Operating profit reached JPY 22.673 billion in fiscal 2027's first quarter, up 27.7 percent year over year.
Meiji Holdings stock traded at JPY 4,268 on October 13, 2026, 7.38 percent below its JPY 4,608 52-week high.
The last Lang & Schwarz quote was EUR 23.50 on October 12, 2026.

Meiji, JP3918000005, Illustration mit AI erstellt.

Meiji Holdings stock traded at JPY 4,268 on October 13, 2026, standing 7.38 percent below its JPY 4,608 52-week high. The company had agreed on September 30, 2026, to establish a joint venture for the generic-drug business of Kyorin Pharmaceutical, with Meiji Seika Pharma holding a 36.0 percent stake, according to Note.

Three milestones shape the year

On August 5, 2026, Meiji disclosed first-quarter results for the fiscal year ending March 2027, according to 6ix. On September 25, 2026, it finalized a restricted-stock allocation of 16,300 shares at JPY 3,805 per share for 163 employees, as reported by The Globe and Mail. The September 30 venture is the latest of the three dated developments.

Pharmaceutical profit is accelerating

In fiscal 2027's first quarter, consolidated sales reached JPY 289.401 billion, up 5.8 percent year over year, while operating profit rose 27.7 percent to JPY 22.673 billion, according to Note. Pharmaceutical operating profit increased 76.3 percent year over year to JPY 8.4 billion, while food operating profit was JPY 15.1 billion on sales of JPY 233.9 billion.

The contrast matters because pharmaceuticals generated a 15.1 percent operating margin in the first quarter, compared with 6.5 percent for food. Cacao sales increased 12.7 percent to JPY 43.6 billion, but cacao operating profit fell 34.2 percent to JPY 2.0 billion as raw-material costs pressured profitability.

What do the dates mean for earnings?

Meiji's next earnings date is November 12, 2026, according to Yahoo Finance. The generic-drug succession is scheduled for April 1, 2027, according to Note.

Stock remains below its yearly high

Meiji Holdings had a market capitalization of JPY 1.2 trillion on October 13, 2026. Its JPY 4,268 Tokyo price was 7.38 percent below the JPY 4,608 52-week high and 46.82 percent above the JPY 2,907 low, leaving the share closer to the upper end of its annual range.

The last available Lang & Schwarz quote was EUR 23.50 on October 12, 2026 at 11:00 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Meiji Holdings stock.